Homeostatic Expansion of T Cells during Immune Insufficiency Generates Autoimmunity  by King, Cecile et al.
Cell, Vol. 117, 265–277, April 16, 2004, Copyright 2004 by Cell Press
Homeostatic Expansion of T Cells during
Immune Insufficiency Generates Autoimmunity
munity remain mysterious. Of particular interest is the
fact that many cases of autoimmunity present with re-
duced numbers of immune cells or lymphocytes (lym-
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Kersten Koelsch,2 and Nora Sarvetnick1,*
1Department of Immunology
The Scripps Research Institute phopenia) (Gleeson et al., 1996; Schaller, 1975). Viruses
that are associated with the triggering of autoimmunity10550 North Torrey Pines Road
La Jolla, California 92037 in humans are known to induce transient lymphopenia
(Bateman et al., 1999; Hernan et al., 2001; Peacock et2 University of California, San Diego
9500 Gilman Drive-0679 al., 2003; Permar et al., 2003). Furthermore, animal mod-
els of autoimmunity often involve the induction of lym-La Jolla, California 92093
phopenia by genetic or experimental means (Fowell et
al., 1991; Powrie et al., 1993; Twarog and Rose, 1970).
This suggests that lymphopenia may facilitate destruc-Summary
tive autoimmunity. Indeed, compensatory homeostatic
expansion, with the ability to favor immune populationsDuring illness and stress, the immune system can suf-
fer a considerable loss of T cells (lymphopenia). The that respond to tissue constituents, may provide a basis
for the development of autoimmunity.remaining T cells undergo vigorous compensatory
expansion, known as homeostatic proliferation, to re- This study tests the hypothesis that lymphopenia and
compensatory homeostatic expansion create autoim-constitute the immune system. Interestingly, human
diseases of autoimmune etiology often present with munity. To address this question, we used a commonly
studied model of autoimmune diabetes, the nonobeseimmune deficiencies such as lymphopenia. In this
study, we show that reduced T cell numbers and the diabetic (NOD) mouse. In this experimental mouse strain,
the target pancreatic insulin-producing  cells are at-resulting exaggerated homeostatic-type proliferation
of T cells generate autoimmunity. The cycling T cell tacked and destroyed by activated T cells, leading to
diabetes. Herein, we demonstrate that lymphopenia andpopulation is short lived, and the depleted memory
compartment fuels the generation of new effector compensatory homeostatic expansion drive autoimmu-
nity in the NOD mouse. Furthermore, we show that re-T cells. A catalyst for these phenomena is the in-
creased responses to the cytokine IL-21, a mediator sponses to the cytokine IL-21 feed this insidious circuit,
creating an unstable niche of effector T cells. Our resultsthat regulates T cell turnover. We conclude that poor
T cell survival and lymphopenia precipitate autoim- uncover a systemic immune failure that underlies the
development of autoimmunity.mune disease.
Introduction Results
The same factors that maintain T cell numbers at a Lymphopenia in NOD Mice
steady state in lymphoid organs also drive their expan- Conveniently, lymphopenia is measured by quantifying
sion following T cell loss. This mechanism, called ho- lymphoid cells. We counted lymphocyte numbers and
meostatic proliferation, is a feature of both naive and found that female diabetes-prone NOD mice have re-
antigen-experienced lymphocytes and is tightly regu- duced numbers of T cells compared to nonautoimmune
lated by both the available space in lymphoid organs strains such as wild-type BALB/c mice. We also com-
and engagement of specific growth factors (Rocha et pared NOD with two additional congenic strains to iden-
al., 1983; Tanchot et al., 1997; Sprent and Surh, 2003). tify lymphopenia-related chromosomal regions. Neither
Interestingly, not all lymphocytes can expand by this the BALB/c strain nor the NOD MHC-matched B10 mice
mechanism. Therefore, homeostatic proliferation may (B10H2g7), which contain the NOD MHC on the B10 back-
affect the nature of T cell populations, favoring the ground and do not develop spontaneous autoimmune
expansion of T cells that are specific for the body’s own diabetes (Figure 1A), were lymphopenic. The lymphope-
constituents (Ernst et al., 1999; La Gruta et al., 2000). nia in NOD mice was attributed to a reduced number
Since autoimmunity is comprised of self-antigen-spe- of CD4 T cells relative to other strains (Figure 1B).
cific responses, such expansion could, in theory, pro- Congenic-B6.Idd3.NOD mice that contain a 0.35 centi-
mote its initiation. morgan protective interval from B6 mice (Denny et al.,
Many fascinating studies have been performed that 1997; Wicker et al., 1994) that includes the leukocyte
address the nature of immune system deficiencies that growth factors IL-2 and IL-21 were not CD4 T cell
lead to autoimmunity. These studies generally focus on lymphopenic (Figure 1B). In addition, NOD mice exhib-
the lack of immune regulatory cells, inappropriate im- ited decreased numbers of B lymphocytes relative to
mune activation, and crossreactive responses to viral B10H2g7 mice and congenic-B6.Idd3.NOD mice (Fig-
antigens. Indeed, the ultimate destruction of tissues at ure 1C).
the end stage of autoimmunity requires true convention-
ally activated responses. However, the origins of autoim- Increasing T Cell Numbers Prevent Diabetes
Previous studies (Sadelain et al., 1990) and our own
observations (Figure 1D) show that immunization with*Correspondence: noras@scripps.edu
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Figure 1. NOD Mice Exhibit Mild Lymphopenia
(A) Absolute T cell numbers are shown from the spleen of NOD (n  59) compared to BALB/c (n  36, p  0.001) and B10H2g7 (n  56, p 
0.001) from 4 weeks of age to 30 weeks of age. (B) Absolute CD4 T cell numbers are shown from the spleen of NOD compared to B10H2g7
(p  0.001) and congenic-B6.Idd3.NOD mice (n  21, p  0.001) and (C) absolute B cell numbers. (D) Immunization with CFA protects NOD
mice from diabetes. (E) T cell numbers are increased following immunostimulation with CFA. Absolute T cell numbers shown for the spleen
of NOD (n  59) and NOD mice that had been immunized with CFA (n  58, p  0.002). (F) Cumulative incidence of diabetes showing the
protective effect of syngeneic infusion of CD4 T cells into NOD mice (n  6).
CFA, which is composed of immune-activating myco- Lymphocytes Expand in the Available Space
To test whether the lymphopenic environment in NODbacterial cell wall constituents, protects NOD mice from
developing diabetes. We tested the idea that such im- mice promotes homeostatic proliferation, we probed the
expansion and cell surface characteristics of experi-munization may lead to an increase in lymphoid cell
numbers, thereby curtailing disease development. In- mentally marked T cells in NOD. Pancreatic  cell-spe-
cific TCR Tg NOD T cells were labeled with 5- anddeed, our results show that CFA-mediated protection
is associated with both acute and long-lasting increases 6-carboxy-fluorescien succinimidyl ester (CFSE), which
halves in intensity at each cell division, and then trans-in T cell numbers in NOD mice (Figure 1E). This result
shows a correlation between immunostimulation, in- ferred into NOD, congenic-B6.Idd3.NOD, CFA-immu-
nized NOD, and NOD mice that had been experimentallycreased T cell numbers, and disease protection. To ask
whether simply increasing T cell numbers would protect “filled” with syngeneic T cells. The TCR transgenic
T cells (Verdaguer et al., 1997) proliferated in the lymphfrom diabetes in NOD mice, we injected NOD mice with
2  107 T cells or 1  107 purified CD4 T cells from nodes of NOD mice as shown by multiple peaks of CFSE
(Figure 2A). In contrast, the TCR transgenic T cells prolif-their NOD littermates. We found that infusion with ex-
cess T cells prevented diabetes development (Figure erated poorly in the lymph nodes of the CFA-immunized
NOD mice, experimentally filled NOD mice, or congenic-1F). This experiment demonstrates that enhanced T cell
numbers, per se, inhibit the development of autoim- B6.Idd3 NOD mice. This demonstrated that the expan-
sion only occurs in lymphopenic mice (Figure 2A). Fur-munity.
Immunodeficiency Generates Autoimmunity
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Figure 2. TCR Tg CD8 T Cells Exhibit Increased Proliferation in NOD Hosts
(A) Proliferation profiles of CFSE-labeled  cell antigen-specific 8.3-NOD TCR Tg CD8 T cells and TCR Tg NOD.HA CD8 T cells recovered
3 days after transfer from the pancreatic lymph nodes, peripheral lymph nodes, and spleen of 11- to 12-week-old unmanipulated NOD,
congenic-B6.Idd3.NOD, CFA-immunized NOD, or NOD hosts infused with syngeneic CD4 T cells. CD8CFSE populations are plotted in
histogram format, and percentages of CFSE-labeled CD8 T cells that have undergone one or more divisions are shown. Representative
plots from three separate experiments are shown, n  4–6 mice per group. Increased T cell proliferation in the secondary lymphoid organs
of NOD mice. Flow cytometric analyses showing the percentages of BrdUCD4CD44hi and BrdUCD8CD44hi T cells from the spleen (B
and C), pancreatic lymph nodes (PLN) (D), and inguinal lymph nodes (inguinal LN) (E) of 8- to 10-week-old mice (n  10–14 mice/group from
five separate experiments) after 8 days on BrdU water. NOD mice have a greater percentage of CD4CD44hi T cells and CD8CD44hi T cells
proliferating in secondary lymphoid organs compared with congenic-B6.Idd3.NOD (p  0.005, p  0.028) or B10H2g7 (p  0.018, p  0.03) or
BALB/c mice (p  0.008, p  0.024, respectively). For the lymph nodes analyses, data is presented as the means plus standard deviations
from five separate experiments.
thermore, influenza hemagglutinin-specific (HA) TCR within the Idd3 locus of the nonautoimmune-prone B6
mice regulate this expansion.transgenic T cells also underwent division in NOD mice
(Figure 2A). The increased proliferation in NOD mice Fortuitously, homeostatically expanding T cells do not
bear the same cell surface markers as conventionallycompared with the B6.Idd3.NOD shows that genes
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activated T cells, which express high levels of CD25 could become tissue destructive. Interestingly, the rap-
idly proliferating CD44 T cells, concentrated in the(IL-2 receptor) and CD69 but have low levels of CD62L,
which is cleaved upon conventional activation. There- S-G2/M fraction (Figure 4A), induced lysis of purified
islet cells from NOD mice (Figure 4B) but did not lysefore, to distinguish between these two types of T cell
expansion, we performed phenotyping experiments. In- control MHC-mismatched islet cells (data not shown).
In contrast, quiescent T cells did not induce lysis of isletterestingly, our results show that NOD mice exhibited
few T cells undergoing conventional activation. This cells from either strain (Figure 4B and data not shown).
More importantly, the actively proliferating (S-G2/M)phenotype was evident for T cells from all of the lymph
nodes of NOD mice, with the exception of the lymph T cell population rapidly induced diabetes in vivo (Figure
4C). Clearly, the T cells undergoing rapid turnover dem-nodes that drain the pancreatic site of autoimmune de-
struction (pancreatic LN), where the proportion of con- onstrated specific self-tissue-destructive capability.
ventionally activated CD4 T cells was the same as
control mice. In contrast, the strains exhibiting no diabe- Increased Expression of IL-21 and Its
tes had higher numbers of conventionally activated Receptor in NOD Mice
T cells (see Supplemental Table S1 at http://www.cell. Residual T cells in lymphopenic environments may be
com/cgi/content/full/117/2/265/DC1). These results confronted with excess quantities of T cell cytokines.
suggest that a significant fraction of the T cells in the Of particular importance are the shared common  chain
NOD autoimmune strain expand homeostatically. binding cytokines that mediate T cell expansion and
Since we have observed lymphopenia in NOD mice, survival, including IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21
we next asked whether this influenced the turnover of (Asao et al., 2001; Leonard et al., 1995). To define the
endogenous T cells in the NOD mice. Groups of BALB/c, proliferative milieu of the autoimmune-prone T cells and
NOD, B10H2g7, and congenic-B6.Idd3.NOD mice rang- thus understand the forces governing their regulation,
ing from 6 weeks of age up to 5 months of age were we examined the steady-state expression of the com-
given the nucleotide analog BrdU (Tough and Sprent, mon  chain (gc) (CD132), the  chain of the IL-2 and IL-
1994). Indeed, we found a much greater percentage of 15 receptors (CD122), and the receptor for interleukin-21
T cells proliferating in NOD mice compared with BALB/c, (IL-21R) on T cells from NOD mice and the congenic-
B10H2g7, or congenic-B6.Idd3.NOD mice (Figures 2B– B6.Idd3 (Table 1). IL-21 is a recently identified c-signal-
2E). This increased percentage of proliferating T cells ing cytokine (Parrish-Novak et al., 2000) and is a putative
was observed in NOD mice from 6 to 20 weeks of age susceptibility gene in the Idd3 locus (Todd and Wicker,
(Figure 2C). 2001). IL-21 is produced by activated CD4 T cells and
costimulates T cell proliferation (Parrish-Novak et al.,
Homeostatic Expansion Correlates with Disease 2000).
We next determined whether increased T cell expansion Interestingly, we found that a greater percentage of
correlated with lymphocyte infiltration into the pancre- T cells from NOD mice express the IL-21R as compared
atic islets. Our analysis revealed that NOD mice with with congenic-B6.Idd3.NOD mice (Table 1). In addition,
the greatest fraction of T cells proliferating in lymphoid the IL-21R was upregulated on T cells from NOD mice
organs exhibited the greatest fraction of islets with insul- as compared with the other control strains and CFA-
itis (Figures 3A and 3C), and those mice with infiltration treated mice (Figure 5A). This was particularly striking
around the islets (peri-insulitis) had the greatest fraction in the memory T cell population (Figure 5A). Indeed, 2- to
of CD4 T cells proliferating locally in the pancreatic 3-fold more memory-phenotype T cells expressed the
lymph nodes (Figure 3B). The degree of most severe IL-21R in NOD mice as compared with the congenic-
destructive inflammation, obscuring the entire islet, cor- B6.Idd3.NOD strain (Table 1). In contrast, the percent-
related with the fraction of rapidly dividing CD8 T cells ages of T cells expressing CD132 and CD122 were de-
(Figure 3D). creased as compared with the congenic- B6.Idd3 mice
We then asked whether exposure to CFA could block (Table 1). These findings indicate that the protective
the vigorous T cell expansion we observed in NOD mice. B6.Idd3 locus, or immunization with CFA, alters the ex-
Indeed, we found that CFA decreased the fraction of pression of receptors for the common  chain binding
proliferating CD8 T cells and CD4 T cells relative to cytokines in NOD mice. Differential receptor expression
control littermates (Figure 3E). Interestingly, in conjunc- would be expected to modify the responsiveness of
tion with this finding, there was a significant reduction T cells to survival-promoting cytokines.
in the percentage of islets infiltrated with lymphocytes The presence of the gene for IL-21 within the Idd3
(Figure 3F and data not shown), accompanied by an susceptibility locus might implicate this cytokine in the
increased fraction of islets surrounded by benign inflam- disease process. Indeed, increased expression of the
mation (Figure 4F). Our data supports the notion that receptor for IL-21 on NOD T cells suggests differences
increased T cell numbers buffer the expansion of self- in exposure to IL-21. To analyze expression of IL-21,
reactive T cells. we used interval-specific RT-PCR TaqMan to determine
relative IL-21 expression levels. Our results show that
unmanipulated lymphocytes from 60% of NOD miceRapidly Proliferating T Cells Are Pathogenic
Homeostatically dividing T cells can eventually acquire tested (n 16) expressed levels of IL-21 mRNA that were
4- to 7-fold greater than the congenic-B6.Idd3.NOD andfunctional features of pathogenic T cells after multiple
rounds of replication (Surh and Sprent, 2000). We asked C57BL/6 mice (Figure 5B). Assessment of IL-7 mRNA
levels, done in parallel, showed an upregulation of IL-7whether the proliferating T cell population in NOD mice
Immunodeficiency Generates Autoimmunity
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Figure 3. Proliferation of CD44hi T Cells in Secondary Lymphoid Organs of NOD Mice Correlates with the Type and Severity of Islet Infiltration
Analyses of pancreatic sections stained for insulin (n  120 islets/group) showing the fraction of islets with peri-insulitis, insulitis (total), and
destructive insulitis (loss of insulin staining). Correlation of the proliferation of CD4 CD44hi T cells in the secondary lymphoid organs of NOD
mice with (A) insulitis and (B) peri-insulitis of the pancreatic islets of Langerhans. Proliferation of CD8 CD44hi T cells in the periphery directly
correlates with (C) insulitis and (D) destructive insulitis. (E) Immunization with CFA causes a significant reduction in the proliferation of CD4
CD44hi T cells (p  0.05) and CD8CD44hi T cells (p  0.026) in the periphery of NOD mice. Percent BrdUCD4CD44hi and BrdUCD8C-
D44hi T cells are shown from the spleens of 12-week-old NOD mice (n  12) versus 12-week-old CFA-immunized NOD mice (n  12) and 20-
week-old NOD mice (n  10) versus 20-week-old CFA-immunized NOD mice. (F) Insulitis indices from sections of pancreata from NOD mice
and CFA-immunized NOD mice, stained for insulin and glucagon, showing percent islets exhibiting peri-insulitis (p  0.016) or insulitis (p 
0.008) (n  112 islets per group).
in only 30% of NOD mice tested (Figure 5B). Importantly, 21 in NOD mice would lead to an (autocrine) increase
in the number of IL-21 receptor-expressing T cells, en-we found that IL-21 exposure leads to upregulation of
its own receptor (Figure 5C). In this regard, excess IL- hancing the responsive population. In support of this,
Figure 4. Actively Proliferating T Cells Cause
Diabetes
CD44 T cells were sorted into two popula-
tions based upon the linear staining intensity
of a cell-permeable DNA (Hoechst 33342) dye
(Sitnicka et al., 1996). (A) Dot plot showing
CD44-PE immunofluorescence on the y axis
and Hoechst 33342-UV fluorescence on the
x axis. Gates are shown for quiescent (G0/
G1) T cells and actively proliferating (S-G2/
M) T cells. (B) Percent lysis of islet cell targets
labeled with chromium. Shown is lysis of islet
cell targets above a background of 26.3%
spontaneous lysis. Results are the mean val-
ues from two separate experiments, in which
n  5 mice. (C) Adoptive transfer of CD44int-
hi T cells in G0/G1 and S-G2/M phases (p 
0.001) from NOD mice (n  8 mice) into NOD/
scid recipients (n  5 mice) from three sepa-
rate experiments.
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Table 1. Percentages of CD122, CD132, and IL-21R-Expressing T Cells
CD122 CD132 IL-21R
Spleen
NOD CD4CD44hi 10.2  2.0 53.7  5.7* 23.3  2.6*
CD4CD44lo 2.1  0.1 40.3  2.8* 10.1  2.1
Congenic-B6.Idd3 CD4CD44hi 11.3  1.2 62.7  3.3* 12.2  1.4*
CD4CD44lo 1.6  0.08 57.1  8.2* 6.6  1.2
NOD CD8CD44hi 26.0  3.8* 58.5  5.3* 30.1  4.0*
CD8CD44lo 5.7  1.1* 51.3  4.4* 7.1  2.9
Congenic-B6.Idd3 CD8CD44hi 36.2  2.7* 70.3  6.7* 11.5  2.1*
CD8CD44lo 10.5  0.9* 69.6  8.1* 4.0  0.5
PLN
NOD CD4CD44hi 1.4  0.3* 45.0  4.8* 16.8  3.3*
CD4CD44lo 0.3  0.02 34.1  2.6* 7.2  1.7*
Congenic-B6.Idd3 CD4CD44hi 8.1  1.1* 60.9  4.9* 8.8  1.7*
CD4CD44lo 2.6  0.4 52.2  3.8* 2.4  1.1*
NOD CD8CD44hi 32.8  1.5* 64.3  5.9 4.7  1.8*
CD8CD44lo 7.8  1.2* 60.2  5.5* 2.2  1.4*
Congenic-B6.Idd3 CD8CD44hi 24.7  1.7* 58.6  7.2 11.6  1.2*
CD8CD44lo 3.6  0.8* 45.3  4.0* 4.0  0.3*
Percentages of CD122, CD132, and IL-21R-expressing T cells are shown from the spleen and PLN of 9-week-old NOD and congenic-B6.Idd3
(n  8 mice per group). Results are the mean values from two separate experiments  SEM, rounded to the nearest integer.
* Values are significantly different between NOD and the congenic B6.Idd3.NOD (Anova).
we observed that a significantly greater percentage of directly compare the survival functions of IL-21 with a
known T cell survival-promoting  chain cytokine,T cells had proliferated in NOD mice in response to
intravenously administered IL-21 than in CFA-immu- namely IL-7, we performed in vitro studies. IL-21 did not
support the survival of T cells at any of the concentra-nized NOD or the congenic-B6.Idd3.NOD mice (Fig-
ure 5D). tions used (Figure 6C). In contrast, IL-7 strongly pro-
moted the survival of CD8 T cells over the 3 day culture
period but had a lesser effect on CD4 T cells (Fig-Reduced Expression of Prosurvival Proteins
ure 6C).Regulation of T cell survival is a critical axis for the
IL-21R T cells are a rapidly proliferating population,maintenance of cell numbers, most notably for long-
as shown by incorporation of BrdU into the majoritylived memory T cells. Indeed, lymphopenia-inducing
(80%) of these cells over a 2 day pulse (Figure 6D,conditions and subsequent homeostatic proliferation re-
Table 2). Their propensity to enter the cell cycle wassult in a biased and permanent loss of long-lived virus-
matched by a reduction in the levels of Bcl-2 and Bcl-specific memory CD8 T cells (Peacock et al., 2003).
XL and increased staining for a preapoptotic markerThe mitochondrial protooncogenes Bcl-2 and Bcl-X(L)
(Annexin-V), compared to T cells that did not expressdelay entry into the cell cycle (O’Reilly et al., 1996), and
the IL-21R (Table 2). In addition, a significantly increasedtheir expression is thought to contribute to the slow
percentage of IL-21R T cells expressed IFN-, the cy-turnover of memory T cells (Zhang et al., 2002). The
tokine that defines autoimmune effector function (Tablelevels of the prosurvival proteins Bcl-2 and Bcl-X(L) are
2). This effector phenotype was more pronounced inincreased upon exposure to several cytokines that sig-
IL-21R T cells from NOD mice, which may reflect in-nal through the c (such as IL-7 and IL-15) and are
creased exposure to IL-21. Taken together, our resultsmaximally increased in memory CD8 and CD4
show that the IL-21R T cells in NOD mice are a highlyT cells, respectively (Akbar et al., 1996; Grayson et al.,
unstable effector population and the source of the phe-2000). In support of this, we found that in disease-resis-
notypic differences that we observed in T cells fromtant B10H2g7, B6.Idd3.NOD, and CFA-immunized NOD,
NOD mice.the levels of Bcl-2 and Bcl-X(L) in memory T cell popula-
tions were greater than those levels observed in naive IL-21 has been reported to signal distinctly through
T cells (Figures 6A and 6B). In contrast, NOD mice exhib- the common  chain compared with other strong prosur-
ited only a negligible increase in Bcl-2 or Bcl-XL in their vival cytokines such as IL-7 and IL-15, activating Stat1
memory T cells (Figures 6A and 6B, respectively). These and Stat3 but not Stat5 (Bennett et al., 2003). We found
results demonstrate a deficit of prosurvival molecules that phosphorylated Stat3 (P-Stat3) was significantly
in memory T cells from NOD mice that would lead to a (4- to 8-fold) augmented in the IL-21R-expressing T cell
paucity of long-lived memory T cells. population compared with T cells that did not express
IL-21R in NOD mice (Table 2). This was most striking in
the CD8 T cells in the PLN of NOD mice (Table 2).IL-21R-Expressing T Cells Are Short Lived
However, we did not observe a corresponding increaseSince IL-21 is augmented in the NOD strain, we deter-
in the percentage of T cells containing phosphorylatedmined whether IL-21 directly influenced the survival of
Stat5 in NOD mice (data not shown). In contrast, P-Stat3T cells and whether the IL-21-responsive T cells were
was not dependent on IL-21 receptor expression in thephenotypically distinct in terms of their rate of expansion
and expression of genes involved in cell survival. To congenic-B6.Idd3.NOD strain (Table 2). Therefore, the
Immunodeficiency Generates Autoimmunity
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Figure 5. Increased Expression of IL-21 and Its Receptor in NOD Mice
Histogram plot overlays showing expression of (A) the receptor for IL-21 on naive (CD44lo) and activated/memory (CD44hi) CD4 and CD8
T cells from the spleen and pancreatic lymph nodes of 8-week-old NOD (red line), compared to age-matched congenic-B6.Idd3.NOD (black
line) or age-matched CFA-immunized NOD mice (black line). Dotted line shows background staining from specificity control in which cells
were pretreated with excess unlabeled IL-21. Representative plots from four separate experiments in which n  12 mice per group. p values
indicate a significant difference (in which p  0.05) in the percentage of T cells expressing the IL-21 receptor. (B) Real-time quantitative PCR
analyses showing fold modulation of cytokine mRNA from three separate experiments: two from whole spleen RNA (black and red circles)
and one from the pancreatic lymph nodes (blue circles) of individual NOD (n  18), congenic-B6.Idd3.NOD (n  11), and C57BL/6 (n  3)
mice. (C) Induction of the IL-21 receptor by its ligand. Histogram plots showing the induction of the IL-21 receptor on CD4 and CD8 T cells
from C57BL/6 mice stimulated for 2 days with anti-CD3 monoclonal antibody and increasing concentrations of rmIL-21. Data are representative
plots from two separate experiments. (D) Flow cytometric analyses of NOD, congenic-B6.Idd3.NOD, and NOD mice that had been neonatally
immunized with CFA (n  8 mice per group). Representative plots from three separate experiments show percentages of CD4 and CD8
T cells that had incorporated BrdU after intravenous administration of 100 ng of rmIL-21 and BrdU water for 2 days plotted against the
activation/memory marker CD44.
IL-21RT cells bear the signature hallmarks of exposure Discussion
to their ligand. These studies indicate that the signal of
distinction in the NOD mouse is IL-21, the culprit creating Our findings indicate that the state of lymphopenia is a
factor that drives the development of autoimmunity.the unstable lymphoid microenvironment in NOD mice.
Cell
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Figure 6. Decreased Survival Signals in NOD T Cells
Levels of (A) Bcl-2 and (B) Bcl-X(L) in naive (CD44lo) and activated/memory (CD44hi) CD4 and CD8 T cells from the spleen and pancreatic
lymph nodes of 7-week-old NOD mice (red line), compared with age-matched B10H2g7 mice, congenic-B6.Idd3.NOD strain, or CFA-immunized
NOD mice (black lines). Representative plots from four separate experiments are shown (n  14 mice per group). p values are shown where
there is a significant difference (where p 0.05) from NOD. (C) Histogram overlays for Bcl-2 levels in CD3 T cells from C57BL/6 mice cultured
for 3 days with either 1 ng/ml of IL-21, 1 ng/ml of IL-7, or media alone. Shown are the percentages of CD4 and CD8 T cells that incorporated
the vital dye 7-AAD after 3 days with or without increasing concentrations of rmIL-7 or IL-21, determined from flow cytometric analyses of
live cells. Representative plots from triplicate determinations showing mean  SEM from three separate experiments. (D) The IL-21 receptor
distinguishes the population of actively proliferating T cells in NOD mice. Representative plots from four separate experiments show percentages
of CD4 CD44hi and CD8 CD44hi T cells that express the receptor for IL-21 and are actively proliferating as determined by incorporation
of BrdU over a 2 day pulse.
NOD mice harbor a labile population of actively ex- teins. Indeed, this population of actively proliferating
T cells in NOD mice is distinguished by their expressionpanding T cells within the depleted memory niche. They
are distinguished from typical memory T cells by a more of the receptor for the costimulatory cytokine IL-21, indi-
cating that increased expression of IL-21 drives thisrapid turnover and by reduced levels of prosurvival pro-
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Table 2. Percentages of IL-21 Receptor-Expressing or Nonexpressing Memory Phenotype CD4 and CD8 T Cells
CD4CD44hi T Cells NOD B6.Idd3.NOD CD8CD44hi T Cells NOD B6.Idd3.NOD
IL-21RBrdU 84.1  8.8 78.3  4.1 IL-21RBrdU 81.3  9.2 78.3  12.8
BrdUIL-21R 34.3  4.1* 18.1  1.1* BrdUIL-21R 54.5  6.2* 26.1  3.3*
IL-21RIFN-g 10.8  1.4* 3.6  0.8* IL-21RIFN-g 21.5  2.8* 8.1  0.7*
IL-21R	IFN-g 0.2  0.06 0.6  0.1 IL-21R	IFN-g 1.9  0.7 1.3  0.3
IL-21RAnnexin 48.3  2.9* 25.7  4.2* IL-21RAnnexin 52.6  11.6* 10.2  1.1*
IL-21R	Annexin 4.8  0.9 5.0  0.4 IL-21R	Annexin 1.5  0.6 0.4  0.2
IL-21RBcl-XL 13.3  1.6* 21.4  3.2* IL-21RBcl-2 19.9  2.4* 31.1  3.0*
IL-21RP-Stat3 7.7  0.7* 12.3  2.1* IL-21RP-Stat3 18.6  1.4 18.9  1.5
IL-21R	P-Stat3 0.9  0.6* 6.7  0.5* IL-21R	P-Stat3 3.0  0.6* 9.3  1.6*
IL-21RP-Stat3 (PLN) 11.4  1.9 11.1  2.1 IL-21RP-Stat3 (PLN) 21.6  1.9* 9.2  1.7*
IL-21R	P-Stat3 (PLN) 1.1  0.1* 5.7  0.1* IL-21R	P-Stat3 (PLN) 1.6  1.2 2.6  0.3
The percentages of IL-21R-expressing (IL-21R) or nonexpressing (IL-21R	) memory phenotype (CD44hi) CD4 and CD8 T cells that are
proliferating (BrdU), apoptotic (Annexin-V), or express interferon-gamma (IFN-g), the prosurvival molecules Bcl-2 or Bcl-XL, or the phosphory-
lated form of Stat3 (P-Stat3) are shown. T cells were analyzed from the spleen and pancreatic lymph nodes of 8-week-old NOD, CFA-immunized
NOD (5 weeks after CFA administration), and congenic-B6.Idd3 (n  14 mice per group). Results are the mean values  SEM from three
separate experiments (n  11 mice/group).
* Value is significantly different (p  0.05) between NOD and the congenic-B6.Idd3.NOD strains.
population of unstable, self-tissue-destructive T cells. humans are precipitated following infection with T cell-
depleting viruses (Bateman et al., 1999; Hernan et al.,We hypothesize that a consequence of these anomalies
is that the constricted NOD T cell pool is unable to buffer 2001; Schaller, 1975) or irradiation and other immuno-
suppressive therapies (Issacs et al., 2001). One broadthe expansion of self-tissue-responsive T cells nurtured
by robust homeostatic factors. This concept is compati- conclusion of this study is that the NOD mouse may be
included in the unifying theme of lymphopenia-associ-ble with the idea that regulation of self-tissue-destruc-
tive T cells occurs via competition for growth-inducing ated autoimmune disease (Gleeson et al., 1996; Theofilo-
poulos et al., 2001). Previous studies collectively demon-resources (Ernst et al., 1999; Kedl et al., 2000). Indeed,
the cytokines and endogenous protein antigens that strate that T cell depletion and its associated expansion
and repopulation of the peripheral lymphoid compart-govern homeostatic expansion may drive the develop-
ment of tissue-destructive T cells. ments lead to increased severity and incidence of IDDM
(Dardenne et al., 1989; Sai et al., 1994). In our T cellImportantly, we show that immune stimulation causes
an increase in T cell numbers and creates a population transfer studies, we show that a relatively small number
of syngeneic T cells can prevent diabetes in recipientof long-lived memory T cells that are otherwise absent
from the NOD strain. Indeed, an extensive list of stimula- mice. However, we cannot rule out a possible effect
from the cotransfer of environmental antigens in thesetory factors is reported to reduce the incidence of diabe-
tes in NOD mice, including the following: persistent viral experiments. In addition to diabetes, other manifesta-
tions of autoimmunity in the NOD mouse and its geneti-infection, mycobacterial infection, complete (heat-killed
mycobacterium-containing) Freund’s adjuvant (CFA), cally manipulated counterparts include mononuclear
cell infiltration of the submandibular and lacrimal glandsand other bacterial antigens (Rabinovitch, 1994). The
“clean” domestic environments of Western societies re- and the presence of circulating autoantibodies (Wicker
et al., 1992) as well as autoimmune neuropathy andsemble the specific pathogen-free conditions under
which NOD mice are housed. This concept of hygiene arthritis (Kouskoff et al., 1996; Salomon et al., 2001).
Therefore, the lymphopenic NOD genetic backgrounddeveloped from the original ideas of Oliver Wendell-
Holmes, Sr., and Ignaz Philipp Semmelweis in the 1840s confers diverse self reactivity.
Increased expression of IL-21 mRNA suggests an in-(Greenhill, 1966) and was subsequently popularized by
Louis Pasteur with his “germ theory of disease” (Mendel- herent differential expression of this cytokine in autoim-
mune NOD mice, but it is equally possible that othersohn, 2002). However, the increase in autoimmunity in
Western societies in recent years (Kukreja and Maclaren, genes in the Idd3 locus may contribute to increased
expression of IL-21. A number of previous studies sup-1999; Kwoh, 1992) may be compounded by the zealous
use of disinfectants and antibiotics during the 20th port the idea that increased responsiveness to IL-21
could play a causal role in generating the disturbedcentury. Indeed, protection from diabetes by immuno-
stimulation with bacterial antigen or infection parallels lymphoid compartments of NOD mice. In this regard,
IL-21 has also been shown to promote apoptosis withthe state of non-Western societal contexts and reflects
the fact that microinoculations can beneficially instruct an associated decrease in Bcl-2 and Bcl-XL levels in B
cells (Mehta et al., 2003). IL-21 has been reported tothe maturation of the immune system in infancy (Holt,
1998). antagonize the effects of the prosurvival cytokine IL-15
(Parrish-Novak et al., 2002). CD122 signaling is abso-A variety of autoimmmune diseases in humans, in-
cluding IDDM (Kaaba and Al-Harbi, 1995), rheumatoid lutely critical for memory CD8 T cells, since it also
confers responsiveness to IL-15, their required growtharthritis, systemic lupus erythematosus, Sjogren’s syn-
drome, ankylosing spondylitis, and Coeliac disease (Di signal. Indeed, we observed that NOD memory CD8
T cells have reduced expression of CD122 relative toSabatino et al., 2001), can present with lymphopenia
(Sleasman, 1996). Furthermore, autoimmune diseases in CFA-immunized and congenic-B6.Idd3 mice. In addi-
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tion, the finding that IL-21 and IL-4 bind overlapping mented immune deficiencies (Kataoka et al., 1983). In
epitopes on the common  chain (Zhang et al., 2003) support of this notion, young NOD mice from colonies
suggests that increased levels of IL-21 may hinder IL-4 with a low incidence of diabetes harbor T cells with a
access, impairing lymphocyte survival (Marrack et al., more activated/memory phenotype than do NOD mice
1998) and favoring a Th-1-type cytokine environment. with a high incidence of diabetes (Berzins et al., 2003;
IL-21 signals through the common  chain, activating Green et al., 2002; Salomon et al., 2000). Indeed, delayed
Stat1 and Stat3 in T cells. However, in contrast to both disease kinetics may reflect the presence of space-filling
IL-7 and IL-15, IL-21 does not activate Stat5 (Bennett immunostimulatory pathogens that inhibit homeostatic
et al., 2003). In support of this, we observed an IL-21R- expansion.
dependent increase in T cells containing P-Stat3 but We propose that organ-specific autoimmunity is initi-
not P-Stat5 in NOD mice. IL-7 and IL-15 mediate some ated by homeostatic proliferation of T cells driven by
of their effects on cell survival gene expression through lymphoid space and costimulated by IL-21. Human au-
the positive effect of Stat5 on Bcl-2 and Bcl-XL expres- toimmune diseases are often associated with viral infec-
sion (Silva et al., 1999; Snow et al., 2003). These differ- tions that disrupt T cell survival mechanisms, resulting
ences in intracellular signaling may contribute to our in lymphopenia. By extension, the pool of host tissue
observation that, in direct contrast to the effects of IL-7, constituents would determine which T cells repopulate
IL-21 had no effect on the survival of T cells in culture the peripheral lymphoid organs (La Gruta et al., 2000).
nor did it support Bcl-2 levels in T cells in vitro. IL- These straightforward parameters explain tissue-spe-
21 has been shown to costimulate T cell proliferation cific autoimmunity. In the context of the inefficient thy-
(Parrish-Novak et al., 2002) and thus may contribute to mic function of NOD mice (Kishimoto and Sprent, 2001),
the high rate of proliferation of endogenous T cells in the exaggerated proliferation of T cells represents unbri-
NOD mice. In this regard, short-term neutralization with dled self reactivity. We concur that a number of factors,
polyclonal anti-mIL-21 substantially reduced the prolif- such as local inflammation and lack of immune regula-
eration of  cell antigen-specific CD8 T cells in NOD tion, are likely to play a role in the end stages of T cell
hosts (data not shown). Taken together, these data sug- activation that precede clinical autoimmunity. However,
gest that IL-21 costimulation of T cell proliferation may in this study, autoimmune disease can be explained by
occur without the promotion of survival or rescue sig- the space-induced expansion of self-reactive lympho-
nals, eventually leading to replicative senescence. IL-21 cytes, fueled by their own demise.
therefore becomes the dominant voice limiting access to
critical survival signals and promoting the expansion of Experimental Procedures
self-tissue-destructive T cells.
Our study complements an interesting previous report Mice
Transgenic mice expressing a TCR specific for an epitope of HArevealing expansion of autoreactive T cells from a re-
that is restricted by MHC class I H-2Kd (Clone-4 TCR) (TCR Tgduced precursor pool in NOD mice (Serreze et al., 2001).
NOD.HA mice) (Morgan et al., 1996) were crossed onto NOD/shi forWe showed that actively dividing (memory-type) T cells
14 generations and were a kind gift from Dr. Linda Sherman. 8.3-
of NOD mice are diabetogenic, a finding in contrast to TCR transgenic NOD mice (8.3-NOD mice) (Verdaguer et al., 1997)
some models in which autoimmune disease following were bred to NOD/scid and maintained in our colony. NOD Ltj mice
homeostatic expansion of naive T cells is prevented by were purchased from Jackson Laboratories, the congenic-C57BL/
6.Idd3(R450).NOD mice were purchased from Taconic Farms, andcotransfer of memory-phenotype T cells (Fowell et al.,
B10H2g7 mice were bred and housed in our colony. Blood glucose1991; Powrie et al., 1993; Twarog and Rose, 1970). How-
values (BGV) were determined using Glucofilm blood glucose stripsever, the T cells of NOD mice are distinguished from
(Miles Diagnostic, Elkhart, IN). All mice were housed together undertypical memory T cells by reduced levels of the prosur-
specific pathogen-free (SPF) housing conditions at the Scripps ro-
vival proteins Bcl-2 and Bcl-XL and increased prolifera- dent colony.
tion. These diabetogenic T cells are rapidly cycling and
short lived, a finding supported by another recent study Immunohistochemical Staining
showing that Bcl-2 overexpression in T cells prevents Paraffin-embedded tissue sections were conventionally stained with
insulitis in NOD mice (Rietz et al., 2003). H&E for histological evaluation or prepared for immunocytochemical
techniques as previously described (Sarvetnick et al., 1990). ForPrevious studies report reduced T cell numbers in
destructive insulitis (loss of insulin staining), insulin-stained sectionssecondary lymphoid organs of NOD mice (Kataoka et
of pancreata were matched to serial sections stained for glucagon.al., 1983; Satoh et al., 1988). However, our findings are
in contrast to a recent report by Berzins et al. showing
Immunostaining for Flow Cytometric Analysessimilar or increased T cells numbers in secondary
To determine absolute cell numbers, lymphocyte cell suspensionslymphoid organs of NOD mice compared to a number
were prepared from spleen and lymph nodes, red blood cells (RBC)
of other nonautoimmune strains (Berzins et al., 2003). were removed by hypotonic lysis, and cells were counted on a
Further, that report showed that NOD mice had lymph Coulter counter. T cells were identified with monoclonal antibodies
nodes that were 20% larger than the other strains, and directed against surface markers (eBiosciences, BD PharMingen,
their T cells had an activated phenotype early in life La Jolla, CA). Intracellular staining for BrdU incorporation was per-
formed according to the manufacturer’s instructions (BrdU labeling-(Berzins et al., 2003) that is not commonly observed
Kit BD PharMingen). Intracellular levels of Bcl-2 (BD PharMingen),(Green et al., 2002; Salomon et al., 2000; Szanya et al.,
Bcl-XL (Santa Cruz Biotechnology, Santa Cruz, CA), phosphorylated2002). One plausible explanation for differences be-
Stat-3, phosphorylated Stat-5 (Upstate, Lake Placid, NY), and IFN-g
tween these studies is that the T cell numbers and their (homegrown biotinylated XMG) were determined using standard
activation status reflect stimulation by environmental procedures (King et al., 2001). Positively stained populations in each
pathogens present in the colony. This is most important instance were determined by gating against isotype control anti-
bodies.in the case of the NOD mouse, which has well-docu-
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BrdU Labeling Experiments Reverse Transcription and Real-Time Quantitative PCR
Total RNA was extracted using the Qiagen RNAeasy procedureMice were given 0.8 mg/ml BrdU in sterile water each day for either
2 days or 8 days total (Tough and Sprent, 1994). For proliferation (Qiagen, Valencia, CA). Complementary DNA (cDNA) was generated
from total RNA using a random hexamer primer, Superscript II (In-in response to IL-21, mice were injected intravenously with 100 ng
of IL-21. vitrogen, Carlsbad, CA). Real-time quantitative PCR analyses were
performed with TaqMan chemistry (Applied Biosystems, Foster City,
CA) and the ABI Prism 7700 Sequence Detection System (AppliedImmunization with Complete Freund’s Adjuvant
Biosystems). Duplicate PCR reactions were cycled at 50
C for 2 minNOD mice were immunized subcutaneously at 3 weeks of age with
and 95
C for 10 min, then at 95
C for 15 s and 60
C for 1 min in 4550 g of complete Freund’s adjuvant at the base of the tail.
cycles. Real-time PCR primers were designed with Primer Express
1.5 (PE Biosystems) software. Values for IL-7 and IL-21 were normal-
Syngeneic Infusion of T Cells ized to GAPDH expression in each sample. Modulation of IL-7 and
Five- to six-week-old NOD mice were injected intravenously with IL-21 in the experimental samples was calculated by employing a
2  107 CD3 T cells or CD4 T cells that had been sorted the comparative CT method (reference sample, 1). mIL-7-35-F, 5-TCC
previous day on a flow cytometer (FACS DIVA) from the spleen of CTC CAC TGA TCC TTG TTC TG-3; mIL-7-115-R, 5-TCT CAT ATG
NOD littermates. CTT TAC CTT CTT TGT CTT T-3; mIL-7-59T, 5-/56-FAM/TGC CTG
TCA CAT CAT CTG AGT GCC AC/3BHQ-1/-3. mIL-21-154F, 5-GAA
CTT CTA TCA GCT CCA CAA GAT GT-3; mIL-21-235R, 5-GCT TGAAdoptive Transfer of T Cells
GTT TGG CCT TCT GAA-3; mIL-21-187T, 5-/56-FAM/CAC TGTDonor NOD.HA or 8.3-NOD CD8 T cells were purified from the
GAG CAT GCA GCT TTT GCC TG/3BHQ-1/-3. Mu GAPDH-247F,spleen and lymph nodes of 8-week-old TCR transgenic mice. Red
5-CAA CGG GAA GCC CAT CAC-3; Mu GAPDH-311R, 5-CGGcells were depleted by hypotonic lysis, and cells were washed and
CCT CAC CCC ATT TG-3; Mu GAPDH-268T, 5-/TET/CTT CCA GGAenriched for naive CD8 T cells by complement depletion with anti-
GCG AGA CCC CAC TAA CA-3.mouse CD4 (YTS 191.1.2), followed by 2 hr adherence on plastic
petri dishes and 2 hr adsorption on nylon wool columns (Poly-
Statistical AnalysesSciences, Inc., Warrington, PA).
Statistical analyses were performed by using ANOVA T test (Stat
View), and Excel was used to determine Gaussian distributions and
5- and 6-Carboxy-Fluorescien Succinimidyl Ester Labeling
line of best fit (R values).
Cells were incubated with 5 M CFSE (Molecular Probes) in HBSS
for 10 min at 37
C. Twelve-week-old normoglycemic NOD female
Acknowledgmentshosts were injected intravenously with 5  106 CFSE-labeled CD8
T cells/200 l of sterile PBS.
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